Breast Clinical Trial
Official title:
Self-Reported Pain and Nadir White Blood Cell/Absolute Neutrophil Count in Women 45 and Under Compared to Older Women Receiving Pegfilgrastim (or Biosimilar Substitution) While Undergoing Chemotherapy for Non-Metastatic Breast Cancer
The overall purpose of this study is to investigate whether younger subjects report pain with pegfilgrastim (or biosimilar substitution) more often and/or at higher levels (greater intensity) than older subjects.This study will be carried out throughout the course of your chemotherapy treatment, which will be prescribed by your study doctor. Participation in this study will not affect your cancer treatment.
This study will measure pain using ESAS self-reported pain scores over the course of one week following each dose of pegfilgrastim (or biosimilar substitution). At the end of that week, blood will be drawn from each subject to directly measure the WBC/ANC, which can then be compared to self-reported pain and evaluated for any correlation. Finally, subjects will be divided into two groups by age: 45 years or younger, and over 45 to look for any differences in pain or WBC/ANC measurements based on age. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04333706 -
A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER)
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT05016310 -
A Study of High-Dose Vit D Versus Standard of Care Vit D Supplementation
|
N/A | |
| Completed |
NCT00026689 -
Evaluation for NCI Radiation Oncology Branch Clinical Research Protocols
|
||
| Active, not recruiting |
NCT04715802 -
Options on the Breast Reconstruction Timing and Method After Removal of Polyacrylamide Hydrogel
|
||
| Recruiting |
NCT05720039 -
Robotic vs. Open NSM for Early Stage Breast Cancer
|
N/A | |
| Recruiting |
NCT06157879 -
Measuring Electrical Properties of Breast Tissues
|
N/A | |
| Completed |
NCT00277069 -
Phase I-II Study of Carboplatin, Vinorelbine and Capecitabine in Patients With Metastatic Breast Cancer
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06083415 -
Early Breast Growth in Girls Aged 6 to 8 Years in the Current Environmental Context
|
N/A | |
| Active, not recruiting |
NCT02734004 -
A Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors.
|
Phase 1/Phase 2 | |
| Recruiting |
NCT03047122 -
Detection of Breast Lesions by Automatic Breast US
|
N/A | |
| Withdrawn |
NCT01114984 -
Post-Breast Procedure Pain Syndrome Study
|
N/A | |
| Recruiting |
NCT05290402 -
Development of an Application-Based Digital Navigator for Perioperative Breast Surgery Patients
|
||
| Active, not recruiting |
NCT01078662 -
Open Label Study to Assess Efficacy and Safety of Olaparib in Confirmed Genetic BRCA1 or BRCA2 Mutation Pats
|
Phase 2 | |
| Not yet recruiting |
NCT05663801 -
Magnesium Sulphate Versus Ketamine as an Adjuvant to Bupivacaine in Pectoral Nerve Block During Mastectomy
|
Phase 2 | |
| Terminated |
NCT00277004 -
Physiological Biomarkers of Cancer Treatment Related Fatigue in Women With Breast Cancer.
|
||
| Completed |
NCT04524728 -
Patterns of Treatment and Outcome of Palbociclib Plus Endocrine Therapy
|
||
| Withdrawn |
NCT00845078 -
Prospective Outcomes After Reconstruction and Radiotherapy for Breast Cancer
|
N/A | |
| Completed |
NCT00972205 -
Paclitaxel and CBT-1(Registered Trademark) to Treat Solid Tumors
|
N/A | |
| Completed |
NCT00064857 -
Pycnogenol for the Treatment of Lymphedema of the Arm in Breast Cancer Survivors
|
Phase 2 | |
| Completed |
NCT03052166 -
Case Collection Study to Determine the Accuracy, Call Back and Cancer Detection Rates of QT Ultrasound in Breast Imaging
|